Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Oxaliplatin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eloxatin 100mg/20ml concentrate for inf vials
0801050ALBBABAB
|
Eloxatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Eloxatin 200mg/40ml concentrate for inf vials
0801050ALBBACAE
|
Eloxatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Eloxatin 50mg/10ml concentrate for inf vials
0801050ALBBAAAA
|
Eloxatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Oxaliplatin 100mg powder for solution for infusion vials
0801050ALAAADAD
|
Oxaliplatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Oxaliplatin 100mg/20ml solution for infusion vials
0801050ALAAABAB
|
Oxaliplatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Oxaliplatin 150mg powder for solution for infusion vials
0801050ALAAAFAF
|
Oxaliplatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Oxaliplatin 200mg/40ml solution for infusion vials
0801050ALAAAEAE
|
Oxaliplatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Oxaliplatin 50mg powder for solution for infusion vials
0801050ALAAACAC
|
Oxaliplatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Oxaliplatin 50mg/10ml solution for infusion vials
0801050ALAAAAAA
|
Oxaliplatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.